Literature DB >> 10392897

Inflammatory pseudotumour secondary to actinomyces infection.

J Evans1, C Chan, L Gluch, I Fielding, R Eckstein.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10392897     DOI: 10.1046/j.1440-1622.1999.01602.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


× No keyword cloud information.
  6 in total

1.  Abdominal actinomycosis simulating malignancy of the right colon.

Authors:  Burak Işik; Engin Aydin; Gokhan Sogutlu; Cengiz Ara; Sezai Yilmaz; Vedat Kirimlioglu
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

2.  Inflammatory myofibroblastic tumor of the small bowel mesentery: an unusual cause of abdominal pain and uveitis.

Authors:  Audrey H Choi; Olga L Bohn; Timothy D Beddow; Christopher R McHenry
Journal:  J Gastrointest Surg       Date:  2011-01-05       Impact factor: 3.452

3.  Actinomyces-induced inflammatory myofibroblastic tumor of the colon: A rare cause of an abdominal mass: Akbulut et al. inflammatory myofibroblastictumor due to actinomyces spp.

Authors:  Sami Akbulut; Yusuf Yagmur; Serdar Gumus; Nilgun Sogutcu; Firat Demircan
Journal:  Int J Surg Case Rep       Date:  2015-02-11

4.  Primary gastric actinomycosis: report of a case diagnosed in a gastroscopic biopsy.

Authors:  Khaleel Al-Obaidy; Fatimah Alruwaii; Areej Al Nemer; Raed Alsulaiman; Zainab Alruwaii; Mohamed A Shawarby
Journal:  BMC Clin Pathol       Date:  2015-02-26

5.  A large inflammatory myofibroblastic tumor involving both stomach and spleen: A case report and review of the literature.

Authors:  Wen-Chao Chen; Zhen-Yu Jiang; Fan Zhou; Zheng-Rong Wu; Gui-Xing Jiang; Bu-Yi Zhang; Li-Ping Cao
Journal:  Oncol Lett       Date:  2014-12-03       Impact factor: 2.967

6.  Gastric inflammatory pseudotumour secondary to Actinomyces hordeovulneris infection in a cat.

Authors:  Marco Pietra; Renato Giulio Zanoni; Angelo Peli; Barbara Brunetti; Nikolina Linta; Ombretta Capitani; Giuseppe Spinella
Journal:  Ir Vet J       Date:  2016-08-26       Impact factor: 2.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.